key: cord-0707419-1mdopdaa
authors: Levolger, Stef; Bokkers, Reinoud P.H.; Wille, Jan; Kropman, Rogier H.J.; de Vries, Jean-Paul P.M.
title: Arterial thrombotic complications in COVID-19 patients
date: 2020-07-17
journal: J Vasc Surg Cases Innov Tech
DOI: 10.1016/j.jvscit.2020.06.012
sha: b9176d031e29950975b37b4cb604e5dc9cc4cb11
doc_id: 707419
cord_uid: 1mdopdaa

The coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been described to predispose to thrombotic disease in both the venous and arterial circulation. We report four cases of an acute arterial occlusion in COVID-19 patients and literature review on the occurrence of arterial thrombosis in patients with COVID-19. Our findings demonstrate that physicians should be vigilant for signs of thrombotic complications in both hospitalized and new COVID-19 patients.

Abstract 1 , The coronavirus disease 2019 (COVID-19) a viral respiratory illness caused by the severe acute 2 respiratory syndrome coronavirus 2 (SARS-CoV-2), has been described to predispose to 3 thrombotic disease in both the venous and arterial circulation. We report four cases of an acute 4 arterial occlusion in COVID-19 patients and literature review on the occurrence of arterial 5 thrombosis in patients with COVID-19. Our findings demonstrate that physicians should be 6 vigilant for signs of thrombotic complications in both hospitalized and new COVID-19 patients. 7 8 Keywords: 9

Arterial occlusion, thrombosis, ischemia, COVID-19, SARS-CoV-2 10 11 Author conflict of interest: none. 12

We report four cases of acute arterial occlusive disease or ischemia in patients with the 2 coronavirus disease 2019 (COVID-19) that is caused by the virus designated severe acute 3 respiratory syndrome coronavirus 2 (SARS-CoV-2). The cases presented at two Dutch hospitals 4 (one university hospital and one large teaching hospital). Since the first presentation of a 5 COVID-19 patient in The Netherlands on February 27 th until May 1 st , 378 reverse transcriptase-6 polymerase chain reaction confirmed patients have been admitted to our two hospitals. Four 7 cases involved an acute arterial occlusion. Medical history, smoking status, laboratory results 8 and anticoagulation therapy are detailed in table 1. 9

The first case was a fifty-year-old healthy male admitted due to pneumonia for which he 10 received supplemental oxygen and chloroquine. Three days after admission the patient developed 11 acute claudication of the right limb without neurological deficits. Computed tomography 12 angiography (CTA) showed a short occlusion (3.5 cm) of the right common iliac artery ( Figure  13 1). Surgical embolectomy was not possible due to a high risk for general anesthesia in relation to 14 COVID-19 and thrombolytic therapy was not available due to capacity issues. After 3 days of 15 systemic therapeutic heparin treatment, the patient was discharged home with mild claudication. 16

Twenty days later the patient was however readmitted with acute ischemia of both legs. CTA 17 showed persistent occlusion of the right common iliac artery. A new thrombus was present at the 18 left tibial-fibular trunk (TTF). The patient subsequently received alteplase for the right common 19 iliac artery and left TTF. Due to the dislodgement of thrombus to the right TTF and persistent 20 ischemia, infragenual exploration and open thrombectomy were performed, with good clinical 21 outcome. 22

The second case was a non-smoking fifty-five-year-old male who was referred with a 1 pale pulseless left hand. There was no muscle weakness and minimal sensory loss of the fingers. 2 CTA was performed and showed a subclavian artery occlusion (Figure 2 ). One week before, the 3 patient had had a fever without other symptoms. At presentation, the patient had no pulmonary 4 symptoms, nor fever and dyspnea. The saturation was 95%. The patient was treated with 5 therapeutic heparin systemically. Because of the absence of fever and hypoxia, no treatment was 6 started for the COVID-19 infection. After one day of heparin treatment, distal pulses were still 7 absent, but refill was normalized, and the function of the hand was completely normalized, with 8 no sensory loss. After two days, rivaroxaban was started and the patient discharged home. 9

The third case is a sixty-two-year-old male who presented with right-sided hemiparesis. 10 CT imaging showed a dense media with corresponding perfusion defect, as well as M1 occlusion 11 on CTA with subtotal stenosis of the internal carotid artery (ICA) origin ( Figure 3 ). There was 12 no known history of ICA stenosis and CTA showed minimal calcified atherosclerosis. The 13 patient underwent intra-arterial thrombectomy with, except some distal cortical emboli, near 14 complete reperfusion. On the second day of admission, the patient developed fever and cough 15 due to COVID-19. Laboratory results were normal. Further symptoms were mild, without the 16 need for supplemental oxygen or other treatment for COVID-19. As of June 9 th , 2020, the patient 17 is still admitted for neurological rehabilitation. 18

The fourth case is a fifty-eight-year-old male who presented with dyspnea and abdominal 19 pain, which had gradually developped within the past two weeks. The patient was admitted to the 20 intensive care unit (ICU) due to respiratory distress the same day. Gastric retention and 21 abdominal distention were noted during the admission and abdominal porto-venous CT imaging 22 was performed, showing dilated small bowel loops, signs of bowel wall ischemia, an adjacent 23 fluid collection, and splenic and renal infarctions without macrovascular arterial occlusion. Non-1 significant stenosing soft plaque was present in the proximal SMA. Subsequent laparotomy was 2 performed and a partial small bowel resection was performed for low flow associated bowel 3 ischemia. Bowel function recovered. Three weeks post-surgery clinically digital necrosis of both 4 feet was observed clinically, arterial duplex was performed and showed no CFA, PFA, SFA or 5 popliteal artery stenosis or occlusion. During recovery the patient has been transferred to a 6 referral hospital. As of June 5 th , 2020 the patient has not yet been discharged . 7 Consent has been given by all patients for the publication of the case details and images. Although an apparent correlation is suggested, possible causality needs to be investigated. 19

Moreover, COVID-19 gives cause to elevated cytokine levels, including but not limited to TNF-20 α, IL-1β, IL-6, and IFN-γ. 16 Prior research has shown elevated levels and exogenous TNF-α may 21 exacerbate focal ischemic injury in stroke as well as intestinal ischemia in an experimental 22

setting. 17-19 Likewise, IL-1β administration leads to increased infarct size whereas lacking IL-1β 23 reduces infarct size in experimental focal cerebral ischemia models. 20 Guidance for 1 considerations in the preventative and therapeutic use of antithrombotic agents as well as 2 potential drug interactions between antiplatelet agents and investigational therapies for COVID-3 19 has recently been published. 21 Further research is warranted to elucidate this suggested 4 association between COVID-19 and ischemic complications, its possible underlying 5 pathogenesis as well as prevention. Fifty-year-old COVID-19 positive male with no medical history developed acute claudication of the right limb without neurological deficits three days after admission. CTA showed short occlusion of the right common iliac artery.

Fifty-five-year-old COVID-19 positive male with a medical history of diabetes with oral metformin use presented with a pale, pulseless left hand without muscle weakness and minimal sensory loss of the fingers. Acquired CTA imaging showed subclavian artery occlusion, depicted (A) sagittal, (B) coronal, and (C) axial. 

High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter 6 prospective cohort study. Intensive Care Medicine

Acute limb 8 ischemia in patients with COVID-19 pneumonia

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Venous 13 and arterial thromboembolic complications in COVID-19 patients admitted to an academic 14 hospital in

Concomitant acute aortic thrombosis and 16 pulmonary embolism complicating COVID-19 pneumonia. Diagn Interv Imaging

Arterial and venous 18 abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia. Radiol Case Rep

Large-Vessel Stroke 21 as a Presenting Feature of Covid-19 in the Young

Characteristics of ischaemic stroke associated with COVID-19

Clinical course and risk factors for 14 mortality of adult inpatients with COVID-19 in Wuhan

Clinical and coagulation 17 characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia

Xue Ye Xue Za Zhi

Can we use interleukin-6 (IL-6) blockade for 20 coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome